US-based Tranzyme, Inc is planning to set up a research and development centre at Hyderabad.
Tranzyme is a drug discovery and development company focused on therapies for diseases associated with the neurosensory system including the eye, ear, chemosensory system (taste and smell) and the brain.
The company’s strengths include a proprietary gene transfer technology (TranzVector), a protein expression technology (TExT), an assay development and drug discovery technology (TranzAssay) and a revolutionary new technology for creating genetically modified animals (TranzEmbryo).
These combined technologies have applications in gene function discovery, in elucidating disease pathways, and creating cell-based assay systems and specialized animal models of disease for drug discovery.
The company has established a dozen strategic partnerships around the world and has secured access to a number of therapeutic targets and lead compounds for neurosensory diseases.